Stress, Psychological
Conditions
Keywords
Audiovisual Aids, Perioperative Period, Anxiety
Brief summary
Little is known about perioperative stress responses and possible anxiety mitigating factors like audiovisual aids or IV sedation. Most studies use surrogate markers and retrospective questionnaires, and are not based on real-time gathered data. Skin conductance measurements allow the sympathetic discharge to be evaluated down to fractions of a second and enable us to continuously monitor stress responses as skin conductance responses/per second during the perioperative management. In our study, the investigators propose to examine the effect of personal audiovisual equipment (audio/video goggles) on perioperative stress, pain, and overall experience in patients undergoing ambulatory meniscectomy under spinal anesthesia. Patients will be randomly assigned to either receive traditional sedation or light sedation in addition to audiovisual equipment. The investigators hope to determine outcome estimates of the use of this equipment on stress levels using skin conductance measurements, request for further sedation, postoperative pain levels and analgesic consumption, time to discharge readiness, and overall patient satisfaction, and collect thus far unavailable data on the stress response to perioperative stresses (such as IV insertion and spinal placement) in order to allow for power analyses for future studies.
Detailed description
PLEASE NOTE: After conducting the interim analysis and plotting the skin conductance data, we have determined that the graphs are not consistent enough to draw any conclusions. Given the technical difficulties we have encountered with the Med-Storm Stress Detector, as well as the labor intensity associated with it, we have decided that we will no longer use it from patient 14 on. We will not mark the time points and hand movements described in the protocol, as this data was used to understand the skin conductance data. We will continue to enroll patients to complete this pilot/exploratory study, as the other secondary outcomes--in particular, the surveys--could provide valuable information.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients scheduled for primary, ambulatory, arthroscopic meniscectomy under spinal anesthesia
Exclusion criteria
* Patients with psychiatric disease and those on antidepressants * Contraindications to spinal anesthesia or allergy to study medication * Age \< 18 years * Patients with audiovisual impairments * Patients with inability to communicate in English or understand the study requirements * Chronic pain patients +/- opioid use * Patients with (neuro)dermatoses encompassing the hand * Patients with pacemakers * Patients with diabetes or known neuropathic disease * Patients with a history of epilepsy or seizure disorder * Patients with a history of claustrophobia * Patients with a history of epilepsy * Patients with prior history of epilepsy or seizure disorder * Patients undergoing a revision or open procedure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Skin Conductance Response | Measured in 5 minute intervals, from holding area until PACU discharge. | Primary outcome will be number of skin conductance responses per second (SCR/sec) and amplitude of skin conductance responses averaged over time in 5 minute intervals and at key time points such before, during and after insertion of an IV, discussion with surgeon, anesthesiologist, immediately before leaving the holding area, immediately after entering the OR, during application of monitors, before and after administration of sedatives, before, during and after spinal insertion, incision, immediately prior to leaving the OR, after arrival at PACU and monitors are placed, before discharge from the PACU. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Systolic and Diastolic Blood Pressure | Measured from preop to postop | The maximum change in postoperative systolic and diastolic blood pressure from holding area until PACU discharge. |
| Respiratory Rate | Measured from preop to postop | The maxmimum change in postoperative respiratory rate from holding area until PACU discharge. |
| Number of Patients Who Requested Additional Sedation | In the operating room | Number of patients who requested additional sedative medication in the operating room. |
| Pain Numerical Rating Scale (NRS) Levels | Holding area, Postop (PACU, 30 minutes after arrival to PACU and POD1) | Pain scores at rest will be collected from patients using the numerical rating scale (NRS), which asks patients to report their level of pain on a scale from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. NRS levels in holding area, PACU until discharge from the PACU and one day after surgery, postop day 1. |
| Narcotic Consumption | Preop until 24 hours after surgery (holding area until POD 1) | Narcotic consumption intraop, postop and POD1 |
| Beats Per Minute (BPM) | Measured from preop to postop | The change in heart rate from holding area until PACU discharge. |
| Heidelberg Peri-anaesthetic Questionnaire | At PACU upon spinal resolution. | The questionnaire consists of 38 questions assessing perioperative satisfaction about five identified themes: trust and atmosphere; fear; discomfort; treatment by personnel; and information and waiting. The questions are rated on a 4-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Higher scores indicate higher levels of satisfaction. Patient satisfaction (Heidelberg Peri-Anaesthetic Questionnaire) in PACU upon spinal resolution. |
| Client Satisfaction Questionnaire (CSQ-8) | PACU upon spinal resolution | The client satisfaction questionnaire (CSQ-8) is a standardized satisfaction measure and was used to collect patient feedback on the audio visual devices. Response options differ, but all are on a 4-point scale. Scores range from 8 to 32, with higher values indicating higher satisfaction. Patient feedback (CSQ8) in PACU upon spinal resolution provider feedback (form sent to providers at end of surgery day) |
| Number of Providers That Were Satisfied With Their Experience With the Audio-visual Aids | Sent to providers at end of surgery. | Anesthesia providers were asked to provide feedback on their experience with the audio-visual aids when the randomization was for the use of the device. This was collected upon surgery end. |
| Request of Sedation/Termination of AVA | From consent until spinal resolution (avg 6 hs) | Request of Sedation/Termination of AVA (After consent has been obtained until spinal resolution in the recovery room, average of 6 hours) |
| Number of Participants With Complications | Intraoperatively and in the recovery room, average of 3 hours | The percentage of patients who experienced complications (headache, transient neurologic symptoms, nausea and vomiting, ...) |
| State-Trait Anxiety Inventory Questionnaire (STAI) | holding area and PACU | Questionnaire to measure state anixety levels based on a 4-point likert scale and consists of 40 questions. The questionnaire measures two types of anxiety: state anxiety and trait anxiety. State anxiety relates to anxiety about an event, while trait anxiety in anxiety level as a personal characteristic. Scores can range from 20 to 80 and higher scores correlate with more anxiety. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Sedation Only With Skin Conductance Monitor Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Midazolam
Skin Conductance Monitor | 13 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor | 13 |
| Total | 26 |
Baseline characteristics
| Characteristic | Sedation Only With Skin Conductance Monitor | Sedation & Audiovisual Aids With Skin Conductance Monitor | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 3 Participants | 0 Participants | 3 Participants |
| Age, Categorical Between 18 and 65 years | 10 Participants | 13 Participants | 23 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 1 Participants | 1 Participants | 2 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 11 Participants | 12 Participants | 23 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 1 Participants | 0 Participants | 1 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 1 Participants | 1 Participants | 2 Participants |
| Race (NIH/OMB) Black or African American | 1 Participants | 0 Participants | 1 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 2 Participants | 1 Participants | 3 Participants |
| Race (NIH/OMB) White | 9 Participants | 11 Participants | 20 Participants |
| Region of Enrollment United States | 13 participants | 13 participants | 26 participants |
| Sex: Female, Male Female | 3 Participants | 0 Participants | 3 Participants |
| Sex: Female, Male Male | 10 Participants | 13 Participants | 23 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 13 | 0 / 13 |
| other Total, other adverse events | 0 / 13 | 0 / 13 |
| serious Total, serious adverse events | 0 / 13 | 0 / 13 |
Outcome results
Skin Conductance Response
Primary outcome will be number of skin conductance responses per second (SCR/sec) and amplitude of skin conductance responses averaged over time in 5 minute intervals and at key time points such before, during and after insertion of an IV, discussion with surgeon, anesthesiologist, immediately before leaving the holding area, immediately after entering the OR, during application of monitors, before and after administration of sedatives, before, during and after spinal insertion, incision, immediately prior to leaving the OR, after arrival at PACU and monitors are placed, before discharge from the PACU.
Time frame: Measured in 5 minute intervals, from holding area until PACU discharge.
Population: We had planned to use the Med-Storm Stress detector to measure skin conductance throughout the procedure until discharge. However, due to repeated technical difficulties with the device and inconclusive data from an analysis of a small number of patients data collection was stopped. No data are presented here.
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Sedation Only With Skin Conductance Monitor | Skin Conductance Response | NA skin conductance responses per second |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Skin Conductance Response | NA skin conductance responses per second |
Beats Per Minute (BPM)
The change in heart rate from holding area until PACU discharge.
Time frame: Measured from preop to postop
Population: Baseline has the heart rate number but analysis for intraop and postop is the change of the variable. Some patients were discharge earlier
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sedation Only With Skin Conductance Monitor | Beats Per Minute (BPM) | BPM Baseline | 71.7 Beats Per Minute | Standard Deviation 10.2 |
| Sedation Only With Skin Conductance Monitor | Beats Per Minute (BPM) | BPM change Intraop | 17 Beats Per Minute | Standard Deviation 27 |
| Sedation Only With Skin Conductance Monitor | Beats Per Minute (BPM) | BPM change Postop | 2 Beats Per Minute | Standard Deviation 10 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Beats Per Minute (BPM) | BPM Baseline | 66.8 Beats Per Minute | Standard Deviation 8.7 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Beats Per Minute (BPM) | BPM change Intraop | 17 Beats Per Minute | Standard Deviation 11 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Beats Per Minute (BPM) | BPM change Postop | -6 Beats Per Minute | Standard Deviation 14 |
Client Satisfaction Questionnaire (CSQ-8)
The client satisfaction questionnaire (CSQ-8) is a standardized satisfaction measure and was used to collect patient feedback on the audio visual devices. Response options differ, but all are on a 4-point scale. Scores range from 8 to 32, with higher values indicating higher satisfaction. Patient feedback (CSQ8) in PACU upon spinal resolution provider feedback (form sent to providers at end of surgery day)
Time frame: PACU upon spinal resolution
Population: This questionnaire was only administered to patients who used the audio-visual aids
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Client Satisfaction Questionnaire (CSQ-8) | 31.5 scores on a scale |
Heidelberg Peri-anaesthetic Questionnaire
The questionnaire consists of 38 questions assessing perioperative satisfaction about five identified themes: trust and atmosphere; fear; discomfort; treatment by personnel; and information and waiting. The questions are rated on a 4-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Higher scores indicate higher levels of satisfaction. Patient satisfaction (Heidelberg Peri-Anaesthetic Questionnaire) in PACU upon spinal resolution.
Time frame: At PACU upon spinal resolution.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Sedation Only With Skin Conductance Monitor | Heidelberg Peri-anaesthetic Questionnaire | 97.2 score on a scale | Standard Deviation 14 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Heidelberg Peri-anaesthetic Questionnaire | 98.9 score on a scale | Standard Deviation 9.5 |
Narcotic Consumption
Narcotic consumption intraop, postop and POD1
Time frame: Preop until 24 hours after surgery (holding area until POD 1)
Population: POD1 - 13 patients from the AVA group were analyzed due to early discharge.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sedation Only With Skin Conductance Monitor | Narcotic Consumption | OME mg Intraop | 2.3 oral morphine equivalents mg | Standard Deviation 8.3 |
| Sedation Only With Skin Conductance Monitor | Narcotic Consumption | OME mg Inpatient postop | 9.8 oral morphine equivalents mg | Standard Deviation 6 |
| Sedation Only With Skin Conductance Monitor | Narcotic Consumption | OME mg POD1 | 11.0 oral morphine equivalents mg | Standard Deviation 9.9 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Narcotic Consumption | OME mg Intraop | 3.5 oral morphine equivalents mg | Standard Deviation 12.5 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Narcotic Consumption | OME mg Inpatient postop | 10.8 oral morphine equivalents mg | Standard Deviation 5 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Narcotic Consumption | OME mg POD1 | 11.5 oral morphine equivalents mg | Standard Deviation 12.3 |
Number of Participants With Complications
The percentage of patients who experienced complications (headache, transient neurologic symptoms, nausea and vomiting, ...)
Time frame: Intraoperatively and in the recovery room, average of 3 hours
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Sedation Only With Skin Conductance Monitor | Number of Participants With Complications | Incidence of Complication Intraop | 0 Participants |
| Sedation Only With Skin Conductance Monitor | Number of Participants With Complications | Incidence of Complication PACU | 0 Participants |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Number of Participants With Complications | Incidence of Complication Intraop | 0 Participants |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Number of Participants With Complications | Incidence of Complication PACU | 0 Participants |
Number of Patients Who Requested Additional Sedation
Number of patients who requested additional sedative medication in the operating room.
Time frame: In the operating room
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Sedation Only With Skin Conductance Monitor | Number of Patients Who Requested Additional Sedation | 5 Participants |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Number of Patients Who Requested Additional Sedation | 3 Participants |
Number of Providers That Were Satisfied With Their Experience With the Audio-visual Aids
Anesthesia providers were asked to provide feedback on their experience with the audio-visual aids when the randomization was for the use of the device. This was collected upon surgery end.
Time frame: Sent to providers at end of surgery.
Population: Providers were only asked to provide feedback on the equipment when used by patients in the audiovisual aid group upon surgery end.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Number of Providers That Were Satisfied With Their Experience With the Audio-visual Aids | 07 Participants |
Pain Numerical Rating Scale (NRS) Levels
Pain scores at rest will be collected from patients using the numerical rating scale (NRS), which asks patients to report their level of pain on a scale from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. NRS levels in holding area, PACU until discharge from the PACU and one day after surgery, postop day 1.
Time frame: Holding area, Postop (PACU, 30 minutes after arrival to PACU and POD1)
Population: Holding area, PACU arrival, 30 minutes after arrival to PACU and POD1.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sedation Only With Skin Conductance Monitor | Pain Numerical Rating Scale (NRS) Levels | Holding area | 1.9 units on a scale | Standard Deviation 1.6 |
| Sedation Only With Skin Conductance Monitor | Pain Numerical Rating Scale (NRS) Levels | PACU arrival | 0 units on a scale | Standard Deviation 0 |
| Sedation Only With Skin Conductance Monitor | Pain Numerical Rating Scale (NRS) Levels | 30 minutes after arrival to PACU | 0.6 units on a scale | Standard Deviation 2.2 |
| Sedation Only With Skin Conductance Monitor | Pain Numerical Rating Scale (NRS) Levels | POD1 | 2.5 units on a scale | Standard Deviation 1.7 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Pain Numerical Rating Scale (NRS) Levels | POD1 | 2.1 units on a scale | Standard Deviation 1.5 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Pain Numerical Rating Scale (NRS) Levels | Holding area | 2.2 units on a scale | Standard Deviation 1.4 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Pain Numerical Rating Scale (NRS) Levels | 30 minutes after arrival to PACU | 0 units on a scale | Standard Deviation 0 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Pain Numerical Rating Scale (NRS) Levels | PACU arrival | 0 units on a scale | Standard Deviation 0 |
Request of Sedation/Termination of AVA
Request of Sedation/Termination of AVA (After consent has been obtained until spinal resolution in the recovery room, average of 6 hours)
Time frame: From consent until spinal resolution (avg 6 hs)
Population: This outcome is only providing findings for subjects that has sedation and audiovisual aids with skin conductance monitor. It does not pertain to subjects that had sedation without the AVA.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Request of Sedation/Termination of AVA | Number of Participants (AVA Randomization) | 13 Participants |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Request of Sedation/Termination of AVA | Request of Sedation/Termination of AVA | 13 Participants |
Respiratory Rate
The maxmimum change in postoperative respiratory rate from holding area until PACU discharge.
Time frame: Measured from preop to postop
Population: Some data was not available for all participants due to equipment not working or due to early discharge
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sedation Only With Skin Conductance Monitor | Respiratory Rate | RR Baseline | 17.2 breaths/minute | Standard Deviation 2.2 |
| Sedation Only With Skin Conductance Monitor | Respiratory Rate | RR change intraop | 5 breaths/minute | Standard Deviation 12 |
| Sedation Only With Skin Conductance Monitor | Respiratory Rate | RR change postop | -1 breaths/minute | Standard Deviation 3 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Respiratory Rate | RR change postop | 1 breaths/minute | Standard Deviation 5 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Respiratory Rate | RR Baseline | 16.9 breaths/minute | Standard Deviation 1.7 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Respiratory Rate | RR change intraop | 4 breaths/minute | Standard Deviation 4 |
State-Trait Anxiety Inventory Questionnaire (STAI)
Questionnaire to measure state anixety levels based on a 4-point likert scale and consists of 40 questions. The questionnaire measures two types of anxiety: state anxiety and trait anxiety. State anxiety relates to anxiety about an event, while trait anxiety in anxiety level as a personal characteristic. Scores can range from 20 to 80 and higher scores correlate with more anxiety.
Time frame: holding area and PACU
Population: 4-point likert scale and consists of 40 questions
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sedation Only With Skin Conductance Monitor | State-Trait Anxiety Inventory Questionnaire (STAI) | STAI-State in holding area | 33.5 score on a scale | Standard Deviation 11.4 |
| Sedation Only With Skin Conductance Monitor | State-Trait Anxiety Inventory Questionnaire (STAI) | STAI-Trait in holding area | 33.4 score on a scale | Standard Deviation 8.9 |
| Sedation Only With Skin Conductance Monitor | State-Trait Anxiety Inventory Questionnaire (STAI) | STAI-State in PACU | 26.1 score on a scale | Standard Deviation 2.6 |
| Sedation Only With Skin Conductance Monitor | State-Trait Anxiety Inventory Questionnaire (STAI) | STAI-Trait in PACU | 32.3 score on a scale | Standard Deviation 9.2 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | State-Trait Anxiety Inventory Questionnaire (STAI) | STAI-Trait in PACU | 32.8 score on a scale | Standard Deviation 9.4 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | State-Trait Anxiety Inventory Questionnaire (STAI) | STAI-State in holding area | 32.3 score on a scale | Standard Deviation 7 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | State-Trait Anxiety Inventory Questionnaire (STAI) | STAI-State in PACU | 27.1 score on a scale | Standard Deviation 5.2 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | State-Trait Anxiety Inventory Questionnaire (STAI) | STAI-Trait in holding area | 31.8 score on a scale | Standard Deviation 6 |
Systolic and Diastolic Blood Pressure
The maximum change in postoperative systolic and diastolic blood pressure from holding area until PACU discharge.
Time frame: Measured from preop to postop
Population: Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) for baseline, intra op and post op was recorded.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sedation Only With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | DBP Baseline | 82.8 mmHg | Standard Deviation 12.7 |
| Sedation Only With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | DBP change intraop | 3 mmHg | Standard Deviation 8 |
| Sedation Only With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | DBP change postop | -2 mmHg | Standard Deviation 11 |
| Sedation Only With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | SBP Baseline | 135.3 mmHg | Standard Deviation 14.5 |
| Sedation Only With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | SBP change intraop | 7 mmHg | Standard Deviation 10 |
| Sedation Only With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | SBP change postop | -8 mmHg | Standard Deviation 13 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | SBP change intraop | 7 mmHg | Standard Deviation 14 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | DBP Baseline | 79.6 mmHg | Standard Deviation 9.5 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | SBP Baseline | 129.2 mmHg | Standard Deviation 15.1 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | DBP change intraop | 2 mmHg | Standard Deviation 7 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | SBP change postop | -2 mmHg | Standard Deviation 15 |
| Sedation & Audiovisual Aids With Skin Conductance Monitor | Systolic and Diastolic Blood Pressure | DBP change postop | -4 mmHg | Standard Deviation 6 |